Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,563 | 286 | 98.2% |
| Education | $191.26 | 9 | 1.8% |
| Travel and Lodging | $5.89 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,654 | 47 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,366 | 24 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $771.64 | 21 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $728.28 | 19 | $0 (2024) |
| ABBVIE INC. | $660.43 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $608.22 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $480.76 | 28 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $425.93 | 17 | $0 (2019) |
| PFIZER INC. | $350.66 | 15 | $0 (2024) |
| Pernix Therapeutics Holdings, Inc. | $339.76 | 8 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,184 | 30 | ABBVIE INC. ($257.21) |
| 2023 | $1,319 | 31 | Teva Pharmaceuticals USA, Inc. ($380.28) |
| 2022 | $1,649 | 34 | Neurocrine Biosciences, Inc. ($668.84) |
| 2021 | $1,874 | 51 | Neurocrine Biosciences, Inc. ($620.32) |
| 2020 | $458.20 | 19 | Lilly USA, LLC ($332.37) |
| 2019 | $806.46 | 29 | Lilly USA, LLC ($200.27) |
| 2018 | $1,645 | 44 | Lilly USA, LLC ($412.57) |
| 2017 | $1,825 | 58 | Pernix Therapeutics Holdings, Inc. ($339.76) |
All Payment Transactions
296 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $123.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Cardio-renal | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Central Nervous System | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $40.11 | General |
| 10/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $16.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: PSYCHIATRY | ||||||
| 08/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $123.91 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Central Nervous System | ||||||
| 08/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: PAIN | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $118.96 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Education | Cash or cash equivalent | $64.99 | General |
| Category: Narcoplepsy | ||||||
| 07/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $123.91 | General |
| Category: Obesity | ||||||
| 05/22/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $13.73 | General |
| Category: Opioid Analgesic | ||||||
| 05/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: PAIN | ||||||
| 05/16/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/08/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $36.39 | General |
| Category: BH | ||||||
| 04/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: PAIN | ||||||
| 03/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Central Nervous System | ||||||
| 03/18/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Central Nervous System | ||||||
| 03/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $63.95 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/06/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 893 | 1,800 | $232,299 | $139,712 |
| 2022 | 7 | 978 | 1,878 | $211,224 | $149,365 |
| 2021 | 7 | 1,000 | 2,133 | $235,177 | $163,286 |
| 2020 | 10 | 945 | 2,655 | $301,849 | $205,167 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 173 | 201 | $49,570 | $27,854 | 56.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 61 | 382 | $31,338 | $22,793 | 72.7% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 119 | 193 | $36,808 | $22,229 | 60.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 140 | 389 | $38,683 | $21,435 | 55.4% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 199 | 224 | $22,918 | $13,578 | 59.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 130 | $22,880 | $13,130 | 57.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 75 | 110 | $15,615 | $8,979 | 57.5% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 35 | 45 | $7,282 | $5,294 | 72.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 21 | 25 | $2,905 | $1,777 | 61.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 20 | 27 | $2,301 | $1,767 | 76.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 74 | $1,998 | $876.60 | 43.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 215 | 241 | $42,203 | $31,755 | 75.2% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 136 | 244 | $34,868 | $25,656 | 73.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 140 | 393 | $28,838 | $20,947 | 72.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 43 | 307 | $22,842 | $16,835 | 73.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 162 | $28,512 | $16,178 | 56.7% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 221 | 247 | $22,449 | $15,493 | 69.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 105 | 182 | $17,658 | $12,858 | 72.8% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Office | 2022 | 22 | 39 | $5,652 | $3,929 | 69.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 13 | 17 | $3,007 | $2,375 | 79.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 23 | 29 | $2,679 | $2,014 | 75.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 17 | $2,516 | $1,326 | 52.7% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 140 | 301 | $43,359 | $33,628 | 77.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 152 | 531 | $39,369 | $27,872 | 70.8% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 171 | 190 | $35,046 | $26,380 | 75.3% |
About Dr. Blaine Jackson, M.D
Dr. Blaine Jackson, M.D is a Internal Medicine healthcare provider based in Solana Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518079565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Blaine Jackson, M.D has received a total of $10,761 in payments from pharmaceutical and medical device companies, with $1,184 received in 2024. These payments were reported across 296 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($10,563).
As a Medicare-enrolled provider, Jackson has provided services to 3,816 Medicare beneficiaries, totaling 8,466 services with total Medicare billing of $657,531. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Solana Beach, CA
- Active Since 08/31/2006
- Last Updated 05/23/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518079565
Products in Payments
- INGREZZA (Drug) $1,113
- REXULTI (Drug) $718.52
- TRULICITY (Drug) $627.08
- Kerendia (Drug) $608.22
- UBRELVY (Drug) $422.42
- XARELTO (Drug) $408.58
- ENTRESTO (Drug) $398.85
- AUSTEDO (Drug) $369.97
- NUEDEXTA (Drug) $319.88
- BAQSIMI (Drug) $303.97
- SILENOR (Drug) $253.48
- QULIPTA (Drug) $242.77
- NURTEC ODT (Drug) $229.88
- Austedo XR (Drug) $227.16
- LATUDA (Drug) $224.03
- ONGENTYS (Drug) $213.09
- SUBLOCADE (Drug) $206.46
- Dayvigo (Drug) $199.30
- NUPLAZID (Drug) $175.70
- MYDAYIS (Drug) $158.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Solana Beach
Daniel Pertschuk, M.d, M.D
Internal Medicine — Payments: $193,379
Robert Yuhas, Md, MD
Internal Medicine — Payments: $9,625
Dr. Mark Kalina, M.d, M.D
Internal Medicine — Payments: $2,933
Heidi Deitch, D.o, D.O
Internal Medicine — Payments: $73.47
Jan Johnston, Md, MD
Internal Medicine — Payments: $71.93
Lawrence Susnow, Md, MD
Internal Medicine